BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 29432061)

  • 21. Influence of SCARB1 polymorphisms on serum lipids of hypercholesterolemic individuals treated with atorvastatin.
    Cerda A; Genvigir FD; Arazi SS; Hirata MH; Dorea EL; Bernik MM; Bertolami MC; Faludi AA; Hirata RD
    Clin Chim Acta; 2010 May; 411(9-10):631-7. PubMed ID: 20064494
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Improvement in cardiometabolic risk markers following an oatmeal diet is associated with gut microbiota in mildly hypercholesterolemic individuals.
    Xu D; Pan D; Liu H; Yang C; Yang X; Wang X; Liu F; Feng M; Wu Q; Shen Y; Yang L; Wang S; Sun G
    Food Res Int; 2022 Oct; 160():111701. PubMed ID: 36076452
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gut Microbiota Differs in Composition and Functionality Between Children With Type 1 Diabetes and MODY2 and Healthy Control Subjects: A Case-Control Study.
    Leiva-Gea I; Sánchez-Alcoholado L; Martín-Tejedor B; Castellano-Castillo D; Moreno-Indias I; Urda-Cardona A; Tinahones FJ; Fernández-García JC; Queipo-Ortuño MI
    Diabetes Care; 2018 Nov; 41(11):2385-2395. PubMed ID: 30224347
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Changes in human gut microbiota composition are linked to the energy metabolic switch during 10 d of Buchinger fasting.
    Mesnage R; Grundler F; Schwiertz A; Le Maho Y; Wilhelmi de Toledo F
    J Nutr Sci; 2019; 8():e36. PubMed ID: 31798864
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Improvement in cardiometabolic risk markers following a multifunctional diet is associated with gut microbial taxa in healthy overweight and obese subjects.
    Marungruang N; Tovar J; Björck I; Hållenius FF
    Eur J Nutr; 2018 Dec; 57(8):2927-2936. PubMed ID: 29098426
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The gut microbiota drives the impact of bile acids and fat source in diet on mouse metabolism.
    Just S; Mondot S; Ecker J; Wegner K; Rath E; Gau L; Streidl T; Hery-Arnaud G; Schmidt S; Lesker TR; Bieth V; Dunkel A; Strowig T; Hofmann T; Haller D; Liebisch G; Gérard P; Rohn S; Lepage P; Clavel T
    Microbiome; 2018 Aug; 6(1):134. PubMed ID: 30071904
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Achieving lipoprotein goals in patients at high risk with severe hypercholesterolemia: efficacy and safety of ezetimibe co-administered with atorvastatin.
    Stein E; Stender S; Mata P; Sager P; Ponsonnet D; Melani L; Lipka L; Suresh R; Maccubbin D; Veltri E;
    Am Heart J; 2004 Sep; 148(3):447-55. PubMed ID: 15389231
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of the Gut Microbiota and Their Metabolites in Modulating the Cholesterol-Lowering Effects of Citrus Pectin Oligosaccharides in C57BL/6 Mice.
    Hu H; Zhang S; Liu F; Zhang P; Muhammad Z; Pan S
    J Agric Food Chem; 2019 Oct; 67(43):11922-11930. PubMed ID: 31576748
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Altered Gut Microbiota Composition Associated with Eczema in Infants.
    Zheng H; Liang H; Wang Y; Miao M; Shi T; Yang F; Liu E; Yuan W; Ji ZS; Li DK
    PLoS One; 2016; 11(11):e0166026. PubMed ID: 27812181
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparative gut microbiota and resistome profiling of intensive care patients receiving selective digestive tract decontamination and healthy subjects.
    Buelow E; Bello González TDJ; Fuentes S; de Steenhuijsen Piters WAA; Lahti L; Bayjanov JR; Majoor EAM; Braat JC; van Mourik MSM; Oostdijk EAN; Willems RJL; Bonten MJM; van Passel MWJ; Smidt H; van Schaik W
    Microbiome; 2017 Aug; 5(1):88. PubMed ID: 28803549
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of neutrophils peptide-1 transgenic Chlorella ellipsoidea on the gut microbiota of male Sprague-Dawley rats, as revealed by high-throughput 16S rRNA sequencing.
    Guo M; Bao Q; Chen S; Cui X; Xu W; He X; Luo Y; Qi X; Huang K
    World J Microbiol Biotechnol; 2016 Mar; 32(3):43. PubMed ID: 26873554
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Faecal bacterial microbiota in patients with cirrhosis and the effect of lactulose administration.
    Sarangi AN; Goel A; Singh A; Sasi A; Aggarwal R
    BMC Gastroenterol; 2017 Nov; 17(1):125. PubMed ID: 29179682
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lipid-altering efficacy and safety of ezetimibe/simvastatin versus atorvastatin in patients with hypercholesterolemia and the metabolic syndrome (from the VYMET study).
    Robinson JG; Ballantyne CM; Grundy SM; Hsueh WA; Parving HH; Rosen JB; Adewale AJ; Polis AB; Tomassini JE; Tershakovec AM
    Am J Cardiol; 2009 Jun; 103(12):1694-702. PubMed ID: 19539078
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Age-related changes in gut microbiota composition from newborn to centenarian: a cross-sectional study.
    Odamaki T; Kato K; Sugahara H; Hashikura N; Takahashi S; Xiao JZ; Abe F; Osawa R
    BMC Microbiol; 2016 May; 16():90. PubMed ID: 27220822
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Helicobacter pylori eradication with bismuth quadruple therapy leads to dysbiosis of gut microbiota with an increased relative abundance of Proteobacteria and decreased relative abundances of Bacteroidetes and Actinobacteria.
    Hsu PI; Pan CY; Kao JY; Tsay FW; Peng NJ; Kao SS; Wang HM; Tsai TJ; Wu DC; Chen CL; Tsai KW;
    Helicobacter; 2018 Aug; 23(4):e12498. PubMed ID: 29897654
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Collateral damage from oral ciprofloxacin versus nitrofurantoin in outpatients with urinary tract infections: a culture-free analysis of gut microbiota.
    Stewardson AJ; Gaïa N; François P; Malhotra-Kumar S; Delémont C; Martinez de Tejada B; Schrenzel J; Harbarth S; Lazarevic V;
    Clin Microbiol Infect; 2015 Apr; 21(4):344.e1-11. PubMed ID: 25658522
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dynamic changes of the luminal and mucosa-associated gut microbiota during and after antibiotic therapy with paromomycin.
    Heinsen FA; Knecht H; Neulinger SC; Schmitz RA; Knecht C; Kühbacher T; Rosenstiel PC; Schreiber S; Friedrichs AK; Ott SJ
    Gut Microbes; 2015 Jul; 6(4):243-54. PubMed ID: 26178862
    [TBL] [Abstract][Full Text] [Related]  

  • 38. N-Acetylcysteine alleviates gut dysbiosis and glucose metabolic disorder in high-fat diet-fed mice.
    Zheng J; Yuan X; Zhang C; Jia P; Jiao S; Zhao X; Yin H; Du Y; Liu H
    J Diabetes; 2019 Jan; 11(1):32-45. PubMed ID: 29845722
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Oryzanol alleviates high fat and cholesterol diet-induced hypercholesterolemia associated with the modulation of the gut microbiota in hamsters.
    Yan S; Chen J; Zhu L; Guo T; Qin D; Hu Z; Han S; Wang J; Matias FB; Wen L; Luo F; Lin Q
    Food Funct; 2022 Apr; 13(8):4486-4501. PubMed ID: 35348138
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Gut Microbiome Contributes to a Substantial Proportion of the Variation in Blood Lipids.
    Fu J; Bonder MJ; Cenit MC; Tigchelaar EF; Maatman A; Dekens JA; Brandsma E; Marczynska J; Imhann F; Weersma RK; Franke L; Poon TW; Xavier RJ; Gevers D; Hofker MH; Wijmenga C; Zhernakova A
    Circ Res; 2015 Oct; 117(9):817-24. PubMed ID: 26358192
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.